Company / Free Cash Flow per Share
Rein Therapeutics, Inc. Free Cash Flow per Share History
FY2017-FY2022 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow per Share
-$5.28
FY2022
5-year range
-$5.28 / -$0.47
FY2018-FY2022
Trend
-1029.3%
vs FY2021
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Free Cash Flow per Share changed -1029% YoY in FY2022, a notable deviation from the 5-year average annual change of -177%.
Based on SEC 10-K filings.
-5.28 in FY2022.
Declined from $-0.96 to $-5.28 over the past 2 years.
Free Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2022, free cash flow per share decreased 1029.3% year-over-year.
- Peak free cash flow per share was recorded in FY2021.
- Lowest free cash flow per share in the period was in FY2017.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -9.18 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | -$5.28 | -1029.3% |
| FY2021 | -$0.47 | +51.2% |
| FY2020 | -$0.96 | +56.4% |
| FY2019 | -$2.19 | -56.2% |
| FY2018 | -$1.40 | +94.9% |
| FY2017 | -$27.30 | - |
As of FY2022 · SEC 10-K · Updated Jun 28, 2026